Wolverine Trading
CERE

Wolverine Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Wolverine Trading’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,700
Closed -$765K – 5550
2024
Q2 		$765K Sell
18,700
-1,000
-5% -$41.6K ﹤0.01% 2440
2024
Q1 		$833K Sell
19,700
-25,900
-57% -$1.09M ﹤0.01% 2366
2023
Q4 		$1.93M Buy
45,600
+21,800
+92% +$626K ﹤0.01% 1740
2023
Q3 		$520K Buy
+23,800
New +$596K ﹤0.01% 2733
2023
Q2 		– Sell
-46,500
Closed -$1.11M – 5146
2023
Q1 		$1.11M Buy
46,500
+33,600
+260% +$986K ﹤0.01% 1805
2022
Q4 		$407K Buy
12,900
+5,000
+63% +$141K ﹤0.01% 2505
2022
Q3 		$220K Buy
7,900
+500
+7% +$14.9K ﹤0.01% 3504
2022
Q2 		$200K Buy
+7,400
New +$210K ﹤0.01% 3558

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Wolverine Trading's CERE Position: Q3 2024 in Review

Wolverine Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 11,198 shares — an estimated $458K sold.

Wolverine Trading first reported a position in CERE in Q1 2023 and held it in 4 quarters. The position peaked at $669K in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Wolverine Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 11,198 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $458K.
  • Wolverine Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Wolverine Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $669K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.